Cohen Veterans Bioscience, Stanford Brain Performance Center, and Brain Trauma Foundation Join Forces to Advance Precision Medicine for TBI apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cohen Veterans Bioscience Joins PRISM 2 Consortium prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Colmar. Musée Unterlinden: des temps d'échanges pour tout découvrir sur la conservation des oeuvres lalsace.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lalsace.fr Daily Mail and Mail on Sunday newspapers.
Cohen Veterans Bioscience Hosts Voices of Veterans Webinar to Mark Mental Health Action Day on May 20, 2021
News provided by
Share this article
Share this article
NEW YORK, May 12, 2021 /PRNewswire/ To commemorate the first Mental Health Action Day, brain research and advocacy nonprofit
Cohen Veterans Bioscience (CVB) announces plans to host a webinar on May 20
th titled
Parachuting with Purpose: A View into the Personal Experiences of Traumatic Brain Injury Among Veterans and a New Path Toward Precision Solutions.
CVB joins more than 700 organizations in its participation in Mental Health Action Day to drive culture from mental health awareness to mental health action.
Cohen Veterans Bioscience And The European College Of Neuropsychopharmacology Announce The 2021 Best Negative Data Prize In Clinical Neuroscience
Sharing Negative Science Results Is Key to Neuroscience Advancement
News provided by
Share this article
Share this article
NEW YORK, March 8, 2021 /PRNewswire/ Cohen Veterans Bioscience (CVB) and the European College of Neuropsychopharmacology (ECNP) are pleased to announce the opening of submissions for the 2021 Best Negative Data Prize in Clinical Neuroscience. The prize recognizes the researcher or research group whose publication in clinical neuroscience best exemplifies clinical data where the results do not confirm the expected outcomes or original hypotheses or results that challenge a long-standing clinical precedent.